GlassScriptPhysician profile
Joseph M Smith
NPI 1417057589
$1,077.13
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $371.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $221.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $92.86 | 2019-2020 | |
| Amgen INC. | $82.50 | 2019-2020 | |
| Lilly USA, LLC | $79.36 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.55 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.79 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $65.69 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $64.49 | 2019 | |
| Pfizer INC. | $55.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $52.60 | 2019-2020 | |
| Abbvie INC. | $40.36 | 2019 | |
| Amarin Pharma, INC. | $38.32 | 2019-2020 | |
| Astellas Pharma US INC | $30.95 | 2019 | |
| Daiichi Sankyo INC. | $18.94 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.50 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.35 | 2020 | |
| Valeritas, INC. | $15.11 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.78 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.23 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.